MEETINGS - Seminar on Preparing for and Passing an FDA Inspection: strategies and tactics to pass a US-FDA inspection first time through (UK) November 1995:
This article was originally published in Clinica
The Institute for Applied Technology is organising a seminar on Preparing for and Passing an FDA Inspection: strategies and tactics to pass a US-FDA inspection first time through on November 30th, 1995, in London, UK. Further information is available from: IAT, PO Box 2115, 1021 Luxembourg. Tel: +352 455 518. Fax: +352 455 905; or IAT, 1358 Busch Parkway, Buffalo Grove, IL 60089, US. Tel: +1 (708) 459 8480. Fax: +1 (708) 459 6644.
You may also be interested in...
Emerging Company Profile: Axcella uses Generally Recognized As Safe (GRAS) amino acids to create drug candidates for hepatic encephalopathy, NASH and other diseases.
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.